Promea Therapeutics

Promea Therapeutics, founded in 2017, is a distinguished manufacturing enterprise specializing in crafting exceptional Life Science products and cutting-edge diagnostics. The company's core offerings include Clinical Chemistry Immunodiagnostics, Molecular Diagnostics, and Infusion Therapies, reflecting its commitment to addressing diverse aspects of healthcare. With a slogan "Your Health. Our Promise," Promea is steadfast in its approach towards customer satisfaction and innovation.

At Promea, a corps of accomplished and dedicated R&D experts drive the unwavering commitment to excellence, epitomizing the pursuit for precision, quality, and ingenuity, which propels the company forward in the competitive life sciences market. Promea's state-of-the-art manufacturing facilities serve as the cornerstone of its operation and exemplify its dedication to quality and innovation, orchestrating the flawless production of kits and devices that consistently transcend expectations.

With a focus on Biopharma, Biotechnology, Health Care, and Manufacturing, Promea Therapeutics has established its headquarters in India, positioning the company in a key hub for the life sciences industry. Currently, there is no public record of the last investment or the investors involved in the most recent funding round for Promea Therapeutics.

In summary, Promea Therapeutics is a promising player in the life sciences sector, exemplifying a commitment to innovation and quality that underpins its product portfolio and manufacturing capabilities. With a strong emphasis on customer satisfaction and a diverse offering of healthcare solutions, the company holds potential for further growth and impact within its target industries.